Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care under Penzyme technology. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Frequently asked questions
What sector does Enzymatica publ AB (ENZY) operate in?
Enzymatica publ AB belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Enzymatica publ AB (ENZY) current stock price?
As of the latest data, Enzymatica publ AB stock price is SEK 2.05, with a previous close of SEK 1.96. Enzymatica publ AB gained SEK 0.10 in the last trading session, representing a 4.86% increase.
What is Enzymatica publ AB (ENZY) current market capitalization?
Enzymatica publ AB market cap is approximately 497.61 million.
What is Enzymatica publ AB (ENZY) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.19.
What is Enzymatica publ AB (ENZY) EBITDA?
Enzymatica publ AB EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -12.41 million.
Does Enzymatica publ AB (ENZY) pay dividends?
No. Enzymatica publ AB does not pay a dividend.
What is Enzymatica publ AB (ENZY) beta (volatility) score?
Enzymatica publ AB has a beta of -0.383, indicating lower volatility than the overall market.